A quality benchmark indicating that at least 98% of the dry weight of a compound is the target molecule, with impurities (related peptides, aggregates, residual solvents) below 2% as confirmed by HPLC peak area integration.
UNIK LABUNIK LAB's minimum purity standard is ≥98%, verified by HPLC for every batch — documented on each CoA.
#The study of how an organism processes a compound over time — encompassing Absorption, Distribution, Metabolism, and Excretion (ADME). PK data guides dosing schedules and route-of-administration choices in preclinical research.
#The study of the biochemical and physiological effects of a compound on the body, and the mechanisms by which those effects are produced. PD examines receptor binding, signal transduction, and downstream biological responses.
#A short chain of amino acids (typically 2–50 residues) linked by peptide bonds (amide bonds between the carboxyl group of one amino acid and the amino group of the next). Peptides act as signalling molecules, hormones, and modulators of biological processes.
#A linear polymer of more than ~50 amino acid residues linked by peptide bonds. When folded into a defined three-dimensional structure with biological activity, a polypeptide is typically classified as a protein.
#The ordered arrangement of amino acid residues in a peptide chain, written either in one-letter code (e.g. MGDQYVPPSS) or three-letter code (e.g. Met-Gly-Asp). Sequence determines three-dimensional structure and biological activity.
#The stage of drug development that occurs before human clinical trials, comprising in vitro (cell-based) and in vivo (animal model) experiments. Preclinical studies assess pharmacokinetics, pharmacodynamics, efficacy, and initial safety profiles.
UNIK LABThe majority of peptides supplied by UNIK LAB have been characterised at the preclinical research stage.
#